content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001750094</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>CLARENDON HOUSE, 2 CHURCH STREET</com:street1>
          <com:city>HAMILTON HM11</com:city>
          <com:stateOrCountry>D0</com:stateOrCountry>
          <com:zipCode>HM11</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>441-295-5950</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Gline Matthew</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza, Floor 5</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>1983257</noOfUnitsSold>
        <aggregateMarketValue>23383087.56</aggregateMarketValue>
        <noOfUnitsOutstanding>739521824</noOfUnitsOutstanding>
        <approxSaleDate>09/23/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>09/20/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Options Exercise - Grant Date 4/20/2022</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1051461</amountOfSecuritiesAcquired>
        <paymentDate>09/20/2024</paymentDate>
        <natureOfPayment>Wire</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Matthew Gline</name>
          <address>
            <com:street1>7th Floor 50 Broadway</com:street1>
            <com:city>London SW1h ODB</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SWIH 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Roivant Sciences LTD</securitiesClassTitle>
        <saleDate>08/20/2024</saleDate>
        <amountOfSecuritiesSold>10947</amountOfSecuritiesSold>
        <grossProceeds>125671.56</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Matthew Gline</name>
          <address>
            <com:street1>7th Floor 50 Broadway,</com:street1>
            <com:city>London SW1H ODB</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1H0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Roivant Sciences LTD</securitiesClassTitle>
        <saleDate>07/20/2024</saleDate>
        <amountOfSecuritiesSold>10945</amountOfSecuritiesSold>
        <grossProceeds>120395.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Mathew Gline</name>
          <address>
            <com:street1>7th Floor 50 Broadway,</com:street1>
            <com:city>London SW1H 0DB</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>SW1h 0DB</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Roivant Sciences LTD</securitiesClassTitle>
        <saleDate>06/20/2024</saleDate>
        <amountOfSecuritiesSold>10945</amountOfSecuritiesSold>
        <grossProceeds>118206.00</grossProceeds>
      </securitiesSoldInPast3Months>
      <remarks>The Reporting person does not expect to sell additional shares of the Issuer for the foreseeable future. Please see attached document for complete list of acquisition of shares( Securities To be sold).</remarks>
      <noticeSignature>
        <noticeDate>09/23/2024</noticeDate>
        <signature>Carmen Zamores as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gline Matthew</signature>
      </noticeSignature>
    </formData>
  
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4935}]
text: 144
  0001750094
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  CLARENDON HOUSE, 2 CHURCH STREET
  HAMILTON HM11
  D0
  HM11
  441-295-5950
  Gline Matthew
  Officer
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza, Floor 5
  New York
  NY
  10111
  1983257
  23383087.56
  739521824
  09/23/2024
  NASDAQ
  Common
  09/20/2024
  Options Exercise - Grant Date 4/20/2022
  Roivant Sciences Ltd.
  N
  1051461
  09/20/2024
  Wire
  N
  Matthew Gline
  7th Floor 50 Broadway
  London SW1h ODB
  X0
  SWIH 0DB
  Roivant Sciences LTD
  08/20/2024
  10947
  125671.56
  Matthew Gline
  7th Floor 50 Broadway,
  London SW1H ODB
  X0
  SW1H0DB
  Roivant Sciences LTD
  07/20/2024
  10945
  120395.00
  Mathew Gline
  7th Floor 50 Broadway,
  London SW1H 0DB
  X0
  SW1h 0DB
  Roivant Sciences LTD
  06/20/2024
  10945
  118206.00
  The Reporting person does not expect to sell additional shares of the Issuer for the foreseeable future. Please see attached document for complete list of acquisition of shares( Securities To be sold).
  09/23/2024
  Carmen Zamores as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gline Matthew